Sun Pharmaceutical Industries Limited has informed the Exchange regarding a press release dated Jun 21, 2024, titled "Sun Pharma signs non-exclusive patent licensing agreement with Takeda for introducing Novel Gastrointestinal Drug, Voltapraz (Vonoprazan) in India".